ArticleFrontiers in immunology2020

CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.

Joanna Bogacka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.